This is based on the comparable expression of PCSK9 and SREBP2 protein levels in the hepatocytes from severely ill patients with and without SARS-CoV-2 infection, as well as similar liver histology and levels of systemic markers of liver disease in cases and controls. The gene discussed is SREBF2; the disease is liver disorder.